← The Wire
IBIONasdaq
iBio, Inc.
Pharmaceutical Preparations · DE · CIK 1420720
iBio uses AI to develop precision antibodies for cardiometabolic and obesity diseases
red 8-K · 90d
$84M
Market cap
$1.73
Last close
+3.6%
1D
-0.6%
5D
1.1M
Volume
Price · last 39 sessions+9.5%
May 4L $1.42 · H $1.93Jun 29
399
Total filings
May 12, 2026
Last filing
06/30
Fiscal year end
10-Q10-QMay 12, 20268-KResults of OperationsMay 12, 20268-KExecutive Change · Reg FD DisclosureMay 8, 20268-K/ACompany UpdateApr 17, 20268-KReg FD Disclosure · Company UpdateApr 8, 20268-KReg FD Disclosure · Company UpdateMar 9, 2026424B5424B5Mar 6, 20268-KMaterial Agreement · Agreement TerminatedFeb 27, 202610-Q10-QFeb 10, 20268-KResults of OperationsFeb 10, 20268-KMaterial Agreement · Equity IssuanceJan 12, 20268-KShareholder VoteNov 21, 20258-KReg FD Disclosure · Company UpdateNov 17, 202510-Q/A10-Q/ANov 17, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KCompany UpdateNov 4, 20258-KReg FD Disclosure · Company UpdateOct 30, 2025DEF 14ADEF 14AOct 6, 202510-K10-KSep 5, 20258-KResults of OperationsSep 5, 20258-KMaterial Agreement · Reg FD DisclosureAug 21, 2025424B5425B5Aug 21, 20258-KResults of Operations · Company UpdateAug 18, 2025424B5424B5Aug 18, 20258-KDelisting NoticeAug 1, 20258-KReg FD Disclosure · Company UpdateJun 24, 20258-KCompany UpdateJun 18, 202510-Q10-QMay 2, 20258-KResults of OperationsMay 2, 2025424B5424B5Apr 30, 2025424B5424B5Apr 30, 2025424B5424B5Apr 30, 20258-KMaterial Agreement · Reg FD DisclosureApr 22, 20258-KReg FD Disclosure · Company UpdateApr 8, 20258-KReg FD Disclosure · Company UpdateApr 7, 20258-KDelisting Notice · Reg FD DisclosureFeb 19, 202510-Q10-QFeb 10, 20258-KResults of OperationsFeb 10, 20258-KMaterial Agreement · Equity IssuanceJan 13, 20258-KReg FD Disclosure · Company UpdateJan 10, 20258-KMaterial Agreement · Equity IssuanceJan 2, 20258-KResults of Operations · Shareholder VoteNov 25, 2024SC 13GSC 13GNov 14, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KReg FD DisclosureOct 23, 2024DEF 14ADEF 14AOct 10, 202410-K/A10-K/ASep 24, 202410-K10-KSep 20, 20248-KResults of OperationsSep 20, 2024424B5424B5Aug 6, 20248-KExecutive ChangeJul 26, 20248-KExecutive Change · Code of EthicsJul 9, 20248-KMaterial AgreementJul 3, 20248-KAgreement Terminated · Acquisition / DispositionJun 5, 20248-KReg FD DisclosureJun 3, 20248-KMaterial Agreement · Equity IssuanceMay 20, 202410-Q10-QMay 13, 20248-KResults of OperationsMay 13, 2024SC 13GSC 13GApr 8, 2024SC 13GSC 13GApr 5, 2024SC 13GIBIO, INC.Apr 1, 20248-KMaterial Agreement · Equity IssuanceApr 1, 20248-KMaterial Agreement · Acquisition / DispositionFeb 26, 20248-KAuditor ChangeFeb 21, 202410-Q10-QFeb 9, 20248-KMaterial Agreement · New Debt / ObligationJan 19, 20248-KReg FD DisclosureJan 8, 2024SC 13GIBIO 13G 1.04.24Jan 4, 20248-KMaterial Agreement · New Debt / ObligationDec 26, 20238-KEquity Issuance · Company UpdateDec 8, 20238-KMaterial Agreement · Company UpdateDec 6, 2023S-1/AS-1/ANov 30, 20238-KExecutive Change · Security-Holder RightsNov 28, 202310-Q10-QNov 14, 2023S-1FORM S-1Oct 27, 2023DEF 14ADEF 14AOct 26, 20238-KMaterial AgreementOct 10, 20238-KReg FD DisclosureOct 2, 2023
Insider Activity
◆ Cluster Buy · 3 insidersIn the 90 days to Mar 26, 2026: 3 insiders bought $98K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Banjak MarcChief Legal Officer | Buy | 12,500 | $1.64 | $21K |
| Mar 26, 2026 | Banjak MarcChief Legal Officer | Buy | 1,434 | $1.76 | $3K |
| Mar 19, 2026 | Duran FelipeChief Financial Officer | Buy | 24,835 | $2.02 | $50K |
| Mar 19, 2026 | Brenner MartinSee Remarks | Buy | 12,336 | $2.02 | $25K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance